154 | Chapter 7 31. Kauer F, van Dalen BM, Michels M, et al. Delayed and decreased LV untwist and unstrain rate in mutation carriers for hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. Published online December 2016:jew213. 32. De S, Borowski AG, Wang H, et al. Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy. Am Heart J. 2011;162(2):262-267.e3. 33. Grover S, Lloyd R, Perry R, et al. Assessment of myocardial oxygenation, strain, and diastology in MYBPC3-related hypertrophic cardiomyopathy: a cardiovascular magnetic resonance and echocardiography study. Eur Heart J Cardiovasc Imaging. 2019;20(8):932-938. 34. Peyrou J, Réant P, Reynaud A, et al. Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography. Int J Cardiovasc Imaging. 2016;32(9):1379-1389. 35. Lie ØH, Rootwelt-Norberg C, Dejgaard LA, et al. Prediction of Life-Threatening Ventricular Arrhythmia in Patients With Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study. JACC Cardiovasc Imaging. 2018;11(10):1377-1386. 36. Leren IS, Saberniak J, Haland TF, Edvardsen T, Haugaa KH. Combination of ECG and Echocardiography for Identification of Arrhythmic Events in Early ARVC. JACC Cardiovasc Imaging. 2017;10(5):503-513. 37. Mast TP, Teske AJ, vd Heijden JF, et al. Left Ventricular Involvement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Assessed by Echocardiography Predicts Adverse Clinical Outcome. J Am Soc Echocardiogr. Published online 2015. 38. Chivulescu M, Lie ØH, Popescu BA, et al. High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy. Eur Heart J. 2020;41(14):1401-1410. 39. Mast TP, Taha K, Cramer MJ, et al. The Prognostic Value of Right Ventricular Deformation Imaging in Early Arrhythmogenic Right Ventricular Cardiomyopathy. JACC Cardiovasc Imaging. 2019;12(3):446455. 40. Taha K, Mast TP, Cramer MJ, et al. Evaluation of Disease Progression in Arrhythmogenic Cardiomyopathy. JACC Cardiovasc Imaging. 2020;13(2):631-634. 41. Mast TP, Teske AJ, Te Riele AS, et al. Prolonged Electromechanical Interval Unmasks Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Subclinical Stage. J Cardiovasc Electrophysiol. 2016;27(3):303-314. 42. Sarvari SI, Haugaa KH, Anfinsen O-G, et al. Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction. Eur Heart J. 2011;32(9):1089-1096. 43. Réant P, Hauer AD, Castelletti S, et al. Epicardial myocardial strain abnormalities may identify the earliest stages of arrhythmogenic cardiomyopathy. Int J Cardiovasc Imaging. 2016;32(4):593-601. 44. Mast TP, Teske AJ, Walmsley J, et al. Right Ventricular Imaging and Computer Simulation for Electromechanical Substrate Characterization in Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Coll Cardiol. 2016;68(20):2185-2197. 45. Aneq MÅ, Engvall J, Brudin L, Nylander E. Evaluation of right and left ventricular function using speckle tracking echocardiography in patients with arrhythmogenic right ventricular cardiomyopathy and their first degree relatives. Cardiovasc Ultrasound. 2012;10(1):37.
RkJQdWJsaXNoZXIy MTk4NDMw